R1 RCM Inc (NASDAQ:RCM) dropped 6.5% during trading on Monday . The company traded as low as $11.32 and last traded at $11.48. Approximately 1,716,516 shares were traded during mid-day trading, an increase of 78% from the average daily volume of 965,611 shares. The stock had previously closed at $12.28.

RCM has been the topic of a number of recent analyst reports. KeyCorp initiated coverage on shares of R1 RCM in a research report on Tuesday, January 22nd. They issued an “overweight” rating and a $10.00 price objective on the stock. BidaskClub downgraded shares of R1 RCM from a “hold” rating to a “sell” rating in a research report on Saturday, January 19th. Zacks Investment Research raised shares of R1 RCM from a “hold” rating to a “buy” rating and set a $11.00 price objective on the stock in a research report on Saturday, March 2nd. Finally, Cantor Fitzgerald increased their price objective on shares of R1 RCM from $11.00 to $13.00 and gave the company an “overweight” rating in a research report on Friday, April 12th. One investment analyst has rated the stock with a sell rating and five have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $14.20.

The company has a current ratio of 0.93, a quick ratio of 1.00 and a debt-to-equity ratio of 118.26. The firm has a market cap of $1.34 billion, a PE ratio of -37.91 and a beta of 0.14.

R1 RCM (NASDAQ:RCM) last issued its earnings results on Thursday, May 9th. The financial services provider reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.01. R1 RCM had a negative net margin of 2.19% and a negative return on equity of 118.28%. The business had revenue of $275.90 million during the quarter, compared to analysts’ expectations of $266.37 million. During the same quarter in the prior year, the business posted ($0.26) EPS. The company’s revenue for the quarter was up 87.3% on a year-over-year basis. Research analysts forecast that R1 RCM Inc will post 0.14 earnings per share for the current year.

Institutional investors have recently modified their holdings of the company. JPMorgan Chase & Co. boosted its holdings in shares of R1 RCM by 244.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 207,326 shares of the financial services provider’s stock valued at $2,106,000 after buying an additional 147,053 shares in the last quarter. Tibra Equities Europe Ltd acquired a new stake in R1 RCM during the 1st quarter worth $462,000. Prudential Financial Inc. boosted its stake in R1 RCM by 104.7% during the 4th quarter. Prudential Financial Inc. now owns 352,570 shares of the financial services provider’s stock worth $2,782,000 after purchasing an additional 180,360 shares during the period. Bank of America Corp DE boosted its stake in R1 RCM by 71.6% during the 4th quarter. Bank of America Corp DE now owns 323,451 shares of the financial services provider’s stock worth $2,571,000 after purchasing an additional 134,974 shares during the period. Finally, Penn Capital Management Co. Inc. boosted its stake in R1 RCM by 8.6% during the 4th quarter. Penn Capital Management Co. Inc. now owns 1,604,732 shares of the financial services provider’s stock worth $13,677,000 after purchasing an additional 126,738 shares during the period. Institutional investors and hedge funds own 66.05% of the company’s stock.

TRADEMARK VIOLATION WARNING: “R1 RCM (RCM) Trading Down 6.5%” was first reported by Daily Political and is the property of of Daily Political. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://www.dailypolitical.com/2019/05/15/r1-rcm-rcm-trading-down-6-5.html.

About R1 RCM (NASDAQ:RCM)

R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.

Recommended Story: What are the benefits of buying treasury bonds?

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.